Release 10.0 is the ‘Security Release’ of Genedata Profiler, the software platform of choice for effective and efficient translational research that delivers on scientific goals while protecting data privacy
Boston, MA, USA (PRWEB) April 05, 2016
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the launch of Release 10.0 of Genedata Profiler, its open, interoperable enterprise software platform for precision medicine designed to facilitate efficient omics-based patient and compound profiling processes. With its strong focus on data security and patient privacy, Release 10.0 addresses translational researchers’ concerns about rapidly-changing and often confusing global regulatory demands.
Genedata Profiler Release 10.0 is study-centric, with user roles defined for each research study and data organized and securely contained at the study level within the software. Genedata Profiler integrates and federates omic and phenotypic data from globally-distributed storage facilities, performs automated data quality assessment (QC) and produces standardized reports. Furthermore, the software comes with user-friendly interfaces and interactive visualizations that allow scientists to quickly identify clinically relevant results. With this release in particular, the chain of custody of data has been strengthened to ensure that research data is traceable and reproducible.
The Genedata Profiler platform extends the level of data security to three layers:
- a new study layer allowing permissions to be defined by scientific role for each research study. For example, an NGS expert can set up a workflow while biologists and analysts on the study team are restricted only to executing it; deletion of data may be authorized for certain defined user roles but not for others;
- an operational layer, with permissions set according to organizationally-defined levels such as Administrator, Manager and User; and
- a physical layer of security which maintains user permissions for data federated from multiple sources, including external file systems.
Supporting high performance computer clusters, Release 10.0 of Genedata Profiler marries data security with performance. The interoperable software platform easily integrates with third party middle-layer software systems such as iRODS (see Genedata completes important milestone on next generation research platform in collaboration with Bayer Pharma AG, September 23, 2015), and its out-of-the-box integration with Active Directory/LDAP reduces software set-up and implementation costs.
“Release 10.0 is the ‘Security Release’ of Genedata Profiler,” commented Dr Othmar Pfannes, CEO of Genedata. “With this latest version of our cutting-edge software for genomic profiling of patients, Genedata has produced a truly security-hardened enterprise solution for research involving omic data from patients in both clinical and less-regulated research environments. Genedata Profiler has cemented its position as the software platform of choice for effective and efficient translational research that delivers on scientific goals while protecting data privacy.”
Genedata scientists are demonstrating Release 10.0 of Genedata Profiler at Booth #335 at Bio-IT World Conference & Expo in Boston, MA, from April 5–7.
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.
Follow us on LinkedIn